At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 20 enrolled
Drug / intervention
1% topical cidofovir +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase II, Randomized, Double-blind, Placebo-controlled, Single-center Proof of Concept Study of Topical Cidofovir for the Prevention of Hair Growth
In Brief
A Phase 2 clinical trial evaluating 1% topical cidofovir, 3% topical cidofovir, and 1 other intervention for Prevention of Hair Growth. Completed, enrolled 20 participants across 1 site.
Detailed Summary
This is a two-arm, single center placebo-controlled double-blind proof of concept study which will evaluate the safety and efficacy of topical cidofovir (both 1% and 3%)compared to placebo for the prevention of hair growth.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPrevention of Hair Growth
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2009
First PostedJul 2009
Primary CompletionMay 2011
TodayJul 2026
First PostedJul 29, 2009
Enrollment StartJul 1, 2009
Primary CompletionMay 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 16.9 years ago
Interventions
1% topical cidofovirdrug
1% topical cidofovir
3% topical cidofovirdrug
3% topical cidofovir
Placebodrug
topical placebo